Anti-MAR11 monoclonal antibody

Pre-made anti-MAR11 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MAR11/11-Mar products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2945-Ab-1/ GM-Tg-hg-IP2945-Ab-2Anti-Human MAR11/11-Mar monoclonal antibodyHuman
GM-Tg-rg-IP2945-Ab-1/ GM-Tg-rg-IP2945-Ab-2Anti-Rat MAR11/11-Mar monoclonal antibodyRat
GM-Tg-mg-IP2945-Ab-1/ GM-Tg-mg-IP2945-Ab-2Anti-Mouse MAR11/11-Mar monoclonal antibodyMouse
GM-Tg-cynog-IP2945-Ab-1/ GM-Tg-cynog-IP2945-Ab-2Anti-Cynomolgus/ Rhesus macaque MAR11/11-Mar monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2945-Ab-1/ GM-Tg-felg-IP2945-Ab-2Anti-Feline MAR11/11-Mar monoclonal antibodyFeline
GM-Tg-cang-IP2945-Ab-1/ GM-Tg-cang-IP2945-Ab-2Anti-Canine MAR11/11-Mar monoclonal antibodyCanine
GM-Tg-bovg-IP2945-Ab-1/ GM-Tg-bovg-IP2945-Ab-2Anti-Bovine MAR11/11-Mar monoclonal antibodyBovine
GM-Tg-equg-IP2945-Ab-1/ GM-Tg-equg-IP2945-Ab-2Anti-Equine MAR11/11-Mar monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2945-Ab-1/ GM-Tg-hg-IP2945-Ab-2; GM-Tg-rg-IP2945-Ab-1/ GM-Tg-rg-IP2945-Ab-2;
GM-Tg-mg-IP2945-Ab-1/ GM-Tg-mg-IP2945-Ab-2; GM-Tg-cynog-IP2945-Ab-1/ GM-Tg-cynog-IP2945-Ab-2;
GM-Tg-felg-IP2945-Ab-1/ GM-Tg-felg-IP2945-Ab-2; GM-Tg-cang-IP2945-Ab-1/ GM-Tg-cang-IP2945-Ab-2;
GM-Tg-bovg-IP2945-Ab-1/ GM-Tg-bovg-IP2945-Ab-2; GM-Tg-equg-IP2945-Ab-1/ GM-Tg-equg-IP2945-Ab-2
Products NameAnti-MAR11/11-Mar monoclonal antibody
Formatmab
Target NameMAR11
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MAR11 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2945-Ag-1Recombinant multi-species MARHB/ MAR11/MAR-11 protein


    Target information

    Target IDGM-IP2945
    Target NameMAR11
    Gene ID441061,211147,499558,717920,479384,101089674,781742,100070090
    Gene Symbol and Synonyms9630025C22,MARCH-XI,MARCH11,MARCHF11,RGD1559945,RNF226
    Uniprot AccessionA6NNE9,A6P320
    Uniprot Entry NameMARHB_HUMAN,MARHB_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183654
    Target ClassificationN/A

    The target: MAR11, gene name: 11-Mar, also named as MARCH-XI, RNF226. MARCH11 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). These enzymes add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their intracellular transport. March11 appears to have a role in ubiquitin-mediated protein sorting in the trans-Golgi network (TGN)-multivesicular body (MVB) transport pathway (Morokuma et al., 2007 [PubMed 17604280]).[supplied by OMIM, Apr 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.